Pian Zihuang responds to "one grain is hard to get": firmly maintain market order and stabilize supply

On June 25, Zhangzhou Pianzihuang Pharmaceutical Co., Ltd. (Pianzihuang, 600436) responded on the interactive platform to the recent phenomenon of "one pill is hard to get" in its tablet tablet, saying that the company's production and operation are in a normal state. In view of the recent market situation, the company has taken three measures to firmly maintain the market order. Specifically speaking, one is to stabilize the supply. The company does a good job in product production and supply, increases the supply of self operated channels and mainstream chain drugstores, and strives to alleviate the contradiction between supply and demand in the market. Second, expand sales channels. The online sales of Pian Zai Huang, the flagship pharmacy of tmall, has been opened, and the layout of Jingdong flagship store has been accelerated. The third is to increase the supply of tablets with the same quality and effect as tablets in order to meet the diversified needs of consumers.

Pianzihuang was founded in 1999 and listed on the Shanghai Stock Exchange in 2003. Its most famous products are Pianzihuang series products with the same name as the enterprise, among which Pianzihuang tablet is its classic product. According to the information on pianzi Huang's official website, its main functions are "clearing away heat and toxin, cooling blood and removing stasis, detumescence and pain relief". It is used for acute and chronic viral hepatitis caused by heat toxin and blood stasis, carbuncle, gangrene and sores, nameless swelling toxin, traumatic injury and various inflammation.

Investors questioned on the interactive platform said: "parents of diabetes cause liver dysfunction, regularly buy Pian Zai eat, but recently to the experience Museum limited to buy 2 grain, in April, ordered 10 grain, now no products." According to previous media reports, the price of Pianzihuang tablets has been rising continuously, from 590 yuan / tablet to 1000 yuan, and there is a shortage of products, and even "one tablet is hard to get" at all stores.

Surging news reporters randomly visited a number of chain drugstores in Shanghai. The staff all said that there is no tablet tablet, but they can buy tablet buccal tablets. A staff member of a drugstore said that it has been out of stock for more than half a year. Before it was out of stock, they even had promotional activities with a price of more than 600 yuan. Now the headquarters is out of stock, so they can register in the drugstore, but there is no guarantee that they are in stock.

As for the reasons for the shortage, the staff of the above-mentioned pharmacies said that it may be related to the epidemic situation. Southeast Asian countries recognize Pianzihuang as a kind of traditional Chinese medicine products, and foreign exports are also very popular.

The surging news reporter noticed that Pian Zihuang replied to investors' questions on the interactive platform at the end of May and mentioned that "Pian Zihuang can't be bought as Maotai". Pian Zihuang said: "we will continue to pay close attention to the terminal market."

The price of Pianzihuang tablet has been rising, and the stock price of Pianzihuang has also been rising recently. As of midday trading on June 25, Pianzihuang closed at 447 yuan per share, up 4.54%, with a market value of 269.68 billion yuan.